Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-09-10 | New | $29,998,991 | $29,998,991 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Charles Berkman | Executive |
Carolyn R. Bertozzi | Director |
Jennifer Cochran | Director |
Steve Crouse | Director |
Matthew W. Foehr | Director, Executive |
Philip J. Gotwals | Director |
Kurt Gustafson | Executive |
John Higgins | Director |
Steve Love | Director |